Volume 4, Issue 4
Editorialp. 387
Predicting time to remission of juvenile dermatomyositis: the role of clinical features
Author(s): E Stringer & B Feldman
Bulletin Boardp. 391
Possible new trigger for chronic inflammation in rheumatoid arthritis discovered
Author(s): News and Event
Bulletin Boardp. 391
Possible new trigger for chronic inflammation in rheumatoid arthritis discovered
Author(s): News and Event
Bulletin Boardp. 392
US FDA approves canakinumab for cryopyrin-associated periodic syndrome
Author(s): News and Event
Bulletin Boardp. 393
Anti-IFN-a lupus vaccine demonstrates positive results in mice
Author(s): News and Event
Bulletin Boardp. 393
Tocilizumab could prevent joint damage and improve physical function in rheumatoid arthritis
Author(s): News and Event
Perspectivep. 395
Treating autoimmune diseases: is stem cell therapy the future?
Author(s): AM Marmont
Perspectivep. 409
Assessing patients with fibromyalgia from a rheumatologist�s perspective: a three-step methodology for differential diagnosis
Author(s): AJ Holman
Review Articlep. 421
Statin therapy for targeting cardiovascular risk in rheumatoid arthritis
Author(s): RJ Bisoendial, ESG Stroes, JJP Kastelein & P-P Tak
Review Articlep. 429
Endomorphins in rheumatoid arthritis, osteoarthritis and experimental arthritis: clinical prospects
Author(s): DS Jessop
Review Articlep. 437
The link between physical activity and bone strength across the lifespan
Author(s): HM Macdonald, MC Ashe & HA McKay
Review Articlep. 465
Rheumatic diseases and Klinefelter�s syndrome
Author(s): J Rovenský & R Imrich
Review Articlep. 473
What�s new in clinical trials in lupus?
Author(s): S Ntali, M Tzanakakis, G Bertsias & DT Boumpas
